Stock CVSI CV SCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases CV Sciences, Inc.

Equities

CVSI

US1266541028

Delayed OTC Markets
Other stock markets
 12:08:16 2024-04-29 pm EDT 		5-day change 1st Jan Change
0.0377 USD +0.13% Intraday chart for CV Sciences, Inc. -0.79% +6.50%
Mar. 28 Transcript : CV Sciences, Inc., Q4 2023 Earnings Call, Mar 28, 2024
Mar. 28 CV Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
CV Sciences, Inc. Reports Fiscal Year-End 2023 Financial Results
PR
CV SCIENCES, INC. TO ANNOUNCE YEAR END AND FOURTH QUARTER 2023 RESULTS ON MARCH 28, 2024
PR
CV Sciences, Inc. Acquires Cultured Foods To Enter Plant-Based Food Market, Opening Door For European Distribution
PR
CV Sciences, Inc. Reports Third Quarter 2023 Financial Results
PR
CV SCIENCES, INC. TO ANNOUNCE THIRD QUARTER 2023 RESULTS ON NOVEMBER 14, 2023
PR
CV Sciences, Inc. Reports Second Quarter 2023 Financial Results
PR
CV SCIENCES, INC. TO ANNOUNCE SECOND QUARTER 2023 RESULTS ON AUGUST 14, 2023
PR
CV SCIENCES, INC. : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)
AQ
CV Sciences, Inc. Reports First Quarter 2023 Financial Results
PR
CV SCIENCES, INC. TO ANNOUNCE FIRST QUARTER 2023 RESULTS ON MAY 15, 2023
PR
CV Sciences, Inc. Introduces New THC Offering
PR
CV SCIENCES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
AQ
CV SCIENCES, INC. : Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
CV Sciences, Inc. Reports Fiscal Year-End 2022 Financial Results
PR
CV SCIENCES, INC. TO ANNOUNCE YEAR END AND FOURTH QUARTER 2022 RESULTS ON MARCH 29, 2023
PR
CV Sciences Receives Formal Notice of Patent Issuance from Japan Patent Office for Formulations Containing Cannabidiol (CBD) and Nicotine for Treating Smokeless Tobacco Addiction
PR
CV Sciences, Inc. Launches New Line of THC-Free Gummies and Softgels
PR
CV SCIENCES, INC. : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
CV Sciences, Inc. Announces Proposed Settlement of Shareholder Litigation
PR
CV Sciences, Inc. Launches 30-Count of Popular +PlusCBD™ Reserve Collection Softgels
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CVSI Stock
  4. News CV Sciences, Inc.
  5. Press Releases